MADRIGAL PHARMACEUTICALS, INC. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e4521d3a-8948-4e87-8d75-e20422a04f78/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-288.3M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-009514 |
| FY 2024 | $-465.9M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-007980 |
| FY 2023 | $-373.6M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-007376 |
| FY 2022 | $-295.2M | 2022-01-01 – 2022-12-31 | evidence 0001308179-26-000352 |
| FY 2021 | $-241.8M | 2021-01-01 – 2021-12-31 | evidence 0001193125-22-051569 |
| FY 2020 | $-202.2M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-056164 |
| FY 2019 | $-83.9M | 2019-01-01 – 2019-12-31 | evidence 0001193125-20-049021 |
| FY 2018 | $-32.8M | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-000725 |
| FY 2017 | $-31.2M | 2017-01-01 – 2017-12-31 | evidence 0001047469-19-000725 |
| FY 2016 | $-26.4M | 2016-01-01 – 2016-12-31 | evidence 0001047469-19-000725 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MADRIGAL PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income